S
Sansure Biotech Inc
SSE:688289
Sansure Biotech Inc
SSE:688289
Price:
20.3
CNY
0.5%
Market Closed
Market Cap:
¥11.8B
Relative Value
The Relative Value of one Sansure Biotech Inc stock under the Base Case scenario is 14.95 CNY. Compared to the current market price of 20.3 CNY, Sansure Biotech Inc is Overvalued by 26%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
14.95
CNY
Overvaluation 26%
S
Multiples Across Competitors
Competitors Multiples
Sansure Biotech Inc Competitors
Sansure Biotech Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
S
|
Sansure Biotech Inc
SSE:688289
|
11.8B CNY | 7 | 43.3 | 47.4 | 47.4 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.3T JPY | 10.4 | 44.2 | 27.6 | 33 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
58.4B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
30.2B CHF | 3.9 | 37.5 | 15.5 | 30.1 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
118.2B DKK | 4.2 | 32.5 | 15 | 17.9 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
11.4B USD | 2.9 | 30.1 | 13.6 | 17.3 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.5B GBP | 2.7 | 28.8 | 12.8 | 20.9 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.6B CNY | 9.4 | 25.8 | 23.3 | 23.3 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.8B USD | 1.2 | -19 | 19.1 | 90.4 | |
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.2B CHF | 5.3 | 21.5 | 14 | 19 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
7.1T KRW | 88.1 | -32.3 | -74.9 | -70.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
